R ecently, high-sensitivity troponin assays have been used to both improve the ability to detect low levels of troponin in healthy individuals and show improved diagnostic sensitivity in patients with suspected acute coronary syndromes. 1, 2 However, most protocols still recommend serial sampling, which results in long lengths of stay and increased costs. 3 High-sensitivity troponin T (hs-cTnT) concentrations below the limit of detection (LoD) have been proposed as a method to rule out acute myocardial infarction (AMI) on arrival to the ED. [4] [5] [6] This study aims to investigate whether hs-cTnT levels below the 99th percentile, when measured at the time of ED arrival, can exclude AMI alone or when combined with negative EKG findings.
ARTICLE SUMMARY
This prospectively planned, secondary analysis of data from a large multicenter trial evaluated the diagnostic characteristics of using hs-cTnT levels below the LoD, along with EKG findings, to rule out AMI on presentation to the ED. The primary outcome was diagnosis of AMI and the secondary outcome was major adverse cardiac events (MACE) within 30 days. A total of 1,282 patients were included in the study, 16.6% of whom were diagnosed with AMI at the index visit.
QUALITY ASSESSMENT
Several limitations to this study were noted. First, this was a secondary analysis of data obtained for a different primary purpose. Secondary analyses have ethical as well as methodologic issues, but in this case, the author states that this was a preplanned analysis and all of the necessary confidentiality precautions were met. In addition, this was a convenience sample. A risk of bias exists when patients are not enrolled consecutively. The authors report a >16% rule in rate in their patient population, which may not represent a similar population of patients undergoing troponin testing in other settings. Finally, the criterion standard for diagnosis of AMI was two independent cardiologists examining all available data, yet blinded to the results of hs-cTnT and routine troponins performed during clinical care. This introduces some subjectivity into the process.
KEY RESULTS
Of the 1,282 patients in the study, 560 had hs-cTnT levels below the level of detection. Of these, 0.7% were diagnosed with AMI; in patients with no EKG ischemia, 0.4% were diagnosed with AMI. Based on the results of this study, hs-cTnT below the limits of detection in patients with no EKG ischemia has a sensitivity of 99.1% (95% confidence interval [CI] = 96.7% to 99.5%), specificity of 43.9% (95% CI = 40.9% to 46.9%), positive predictive value of 26% (95% CI = 23% to 29.2%), negative predictive value of 99.6% (95% CI = 98.5% to 100%), positive likelihood ratio of 1.76 (95% CI = 1.67 to 1.86), and negative likelihood ratio of 0.02 (95% CI = 0.01 to 0.09) for AMI.
AUTHORS' COMMENTS
High-sensitivity troponin testing at extremely low levels has high sensitivity and high rule-out value for AMI, especially with combined with a normal EKG. Based on the results of this paper, a strategy using hs-cTnT levels below the LoD (<5 ng/L) at the time of arrival to the ED, along with EKG testing, could allow providers to rule out AMI and MACE with confidence without further cardiac testing.
TOP SOCIAL MEDIA COMMENTARY
Comments from theSGEM.com Andrew Worster. Rick, I confess, the more I study troponin, the less I understand about it. I really think that we need to move from test performance characteristic studies to pragmatic clinical trials for patients with chest pain of suspected ischemic origin in community settings. I also think that you are the one of the best researchers to lead such studies.
Daniel McCollum. Fantastic discussion of a really interesting article. How might this change my practice once the US finally gets widely available high sensitivity troponins? I think the days of binary yes/no decision making for the assessment of chest pain are over. The authors of this study do an admirable job of not just lumping everyone together, but dividing patients based on presence of ECG changes and age. I love that they included data on the 4 patients with missed AMI with hs-cTnT < LoD. Old people aren't to be trusted, and I would be very hesitant in using any single troponin rule out in anyone that is elderly.
Bayesian thinking will be required to properly use these high sensitivity assays. Patients that are young, have a normal ECG, pain for at least a couple hours, and a history of present illness that are not very concerning can likely be ruled out with a single hs-cTnT with acceptably low risk rates. I personally would prefer at least a 2 hour delta troponin for anyone that doesn't fit into the above group.
Dr. Body's reply: Dan, many thanks for your kind comments! I read your comments with great interest. I always like to know how other people interpret the study with an external perception and your observations are very considered.
Of note, although it's a secondary analysis it is actually still a prospective study: the participants were selected for inclusion (and data collected for the study) before outcomes were known. We published another prospective validation of this strategy at the link below (although it was also a secondary analysis) -it's open access . . . 
TAKE-TO-WORK POINTS
High-sensitivity troponin T testing at the time of arrival to the ED, along with a normal EKG, may be an effective method to exclude AMI and 30-day MACE with a high degree of certainty. Shared decision-making with patients is necessary to ensure that they understand that no testing is 100% accurate.
